OpenAlex
PricingAboutJobs
Log inGet started
Work

Therapeutic use of anti-CTLA-4 antibodies

HTML

Year: 2014
Type: review
Source: International Immunology
DOI: 10.1093/intimm/dxu076
Authors: Christian U. Blank, Alexander Enk
Institutions: The Netherlands Cancer Institute, Heidelberg University
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: CTLA-4 blockade, ipilimumab, immune checkpoint blockade, melanoma, PD-1/PD-L1, cancer immunotherapy, treatment response biomarkers, mechanism of action
SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, GlaxoSmithKline, Cilag
OpenAlex ID: W2107075226
FWCI: 1.51
Cites: 89
Cited by: 133
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security